Cytocom, Inc.
CBLI · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2 | -$3 | -$4 | -$10 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1 | -$3 | -$4 | -$5 |
| Other Non-Cash | -$1 | $3 | $3 | $8 |
| Operating Cash Flow | -$2 | -$3 | -$5 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1 | -$1 | -$8 | -$9 |
| Inv. Sales/Matur. | $1 | $1 | $12 | $13 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $4 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $0 | $0 | $0 |
| Financing Cash Flow | $3 | $0 | $0 | $0 |
| Forex Effect | -$0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $1 | -$2 | -$1 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $4 | $4 | $7 |
| End Cash | $2 | $1 | $4 | $4 |
| Free Cash Flow | -$2 | -$3 | -$5 | -$7 |